97278-75-6

Basic information

• Product Name: 1-benzyloxycarbonylmethyl-3-(1-ethoxycarbonyl-3-phenyl-(1S)-propylamino)-3,4,5,6-tetrahydro-(3R)-1-benzazocin-2-1H-one
• Synonyms: 1-benzyloxycarbonylmethyl-3-(1-ethoxycarbonyl-3-phenyl-(1S)-propylamino)-3,4,5,6-tetrahydro-(3R)-1-benzazocin-2-1H-one
• CAS NO: 97278-75-6
• Molecular Weight: 528.648
• Mol File: 97278-75-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-benzyloxycarbonylmethyl-3-(1-ethoxycarbonyl-3-phenyl-(1S)-propylamino)-3,4,5,6-tetrahydro-(3R)-1-benzazocin-2-1H-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyloxycarbonylmethyl-3-(1-ethoxycarbonyl-3-phenyl-(1S)-propylamino)-3,4,5,6-tetrahydro-(3R)-1-benzazocin-2-1H-one(97278-75-6)
• EPA Substance Registry System: 1-benzyloxycarbonylmethyl-3-(1-ethoxycarbonyl-3-phenyl-(1S)-propylamino)-3,4,5,6-tetrahydro-(3R)-1-benzazocin-2-1H-one(97278-75-6)

Safety Data

• Hazardous Substances Data: 97278-75-6(Hazardous Substances Data)

Upstream product

• 101386-40-7 (R)-2-[1-Benzyloxycarbonylmethyl-2-oxo-1,4,5,6-tetrahydro-2H-benzo[b]azocin-(3E)-ylideneamino]-4-phenyl-butyric acid ethyl ester 
• 683-18-1 dibutyltin chloride 
• 46460-23-5 ethyl 2-amino-4-phenyl-(2S)-butyrate 
• 97278-73-4 1-<(carbobenzyloxy)methyl>-3,4,5,6-tetrahydro-1-benzazocine-2,3(1H)-dione 
• 91167-28-1 3-bromo-3,4,5,6-tetrahydro-1-benzazocin-2(1H)-one 
• 22246-75-9 3,4,5,6-tetrahydro-1-benzazocin-2(1H)-one 
• 97278-72-3 3-azido-3,4,5,6-tetrahydro-1-benzazocin-2(1H)-one 

Relevant articles and documents

Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme

Syntheses of the potent angiotensin converting enzyme inhibitor (3S)-1-(carboxymethyl)-3-[[(1S)-1-carboxy-3-phenylpropyl]amino]-2,3,4,5 -tetrahydro-1H-[1]benzazepin-2-one (CGS 14831) and the related monoester prodrug (17a; CGS 14824A) are described together with preparative details for six- and eight-membered ring analogues. Inhibitory potencies and in vivo biological activity of the compounds are discussed. The data indicate that 17a has a biological profile comparable to that of enalapril.